Biochemical abnormalities in a chronic carrier of hepatitis B are:

Questions 180

ATI RN

ATI RN Test Bank

Pediatric Cardiovascular Disorders Nursing Questions

Question 1 of 5

Biochemical abnormalities in a chronic carrier of hepatitis B are:

Correct Answer: A

Rationale: In a chronic carrier of Hepatitis B, biochemical abnormalities can provide important diagnostic information. The correct answer, option A (Raised AST - aspartate aminotransferase), is indicative of liver inflammation or damage, which is commonly seen in hepatitis B infection. AST is an enzyme found in high levels in the liver, heart, muscles, and other tissues, and elevated levels in the blood indicate liver cell damage, making it a key marker in assessing liver health in hepatitis B patients. Option B (Low serum albumin) is not typically associated with hepatitis B infection. Low serum albumin levels are more commonly seen in conditions affecting protein synthesis or liver function over a longer period of time, rather than in acute or chronic hepatitis B infection. Option C (Raised gamma GT - gamma-glutamyl transferase) is not a specific marker for hepatitis B infection. Elevated levels of gamma GT can be seen in various liver and biliary tract diseases, but it is not a primary marker for hepatitis B infection. Option D (Raised transferrin) is also not a typical marker for hepatitis B infection. Transferrin is a protein involved in iron transport, and elevated levels are more commonly associated with iron overload conditions rather than hepatitis B infection. To provide educational context, it is important for nursing students specializing in pediatric cardiovascular disorders to understand the significance of biochemical markers in liver function tests, especially in the context of chronic viral infections like hepatitis B. Understanding these markers can aid in diagnosis, monitoring disease progression, and assessing treatment efficacy in pediatric patients with chronic hepatitis B infection.

Question 2 of 5

Recurrent headaches in childhood are seen with:

Correct Answer: B

Rationale: In pediatric pharmacology, understanding common pediatric cardiovascular disorders is essential for nursing practice. The correct answer is B) Migraine. Recurrent headaches in childhood are often associated with migraines due to their episodic nature, which can be triggered by various factors such as stress, lack of sleep, certain foods, or hormonal changes. Migraines have specific characteristics like throbbing pain, sensitivity to light and sound, and can be accompanied by nausea and vomiting, which are common in children experiencing recurrent headaches. Option A) Tension headaches are less likely in children and are more common in adults due to stress or musculoskeletal issues. Sinusitis (Option C) typically presents with symptoms like facial pain, nasal congestion, and fever, rather than recurrent headaches. Hypermetropia (Option D), or farsightedness, is a refractive error of the eye and is not directly linked to recurrent headaches. Educationally, it is important for nurses to recognize the different types of headaches in children to provide appropriate care and management. Understanding the specific characteristics and triggers of migraines can help nurses differentiate them from other types of headaches and ensure proper treatment and support for pediatric patients experiencing recurrent headaches.

Question 3 of 5

Uncommon complications of severe falciparum malaria are:

Correct Answer: A

Rationale: In pediatric patients with severe falciparum malaria, uncommon complications can arise, such as a stroke. The correct answer is A) Stroke. This is due to the potential for cerebral malaria, which can lead to impaired consciousness, seizures, and potentially stroke-like symptoms. Understanding this complication is crucial for nurses caring for pediatric patients with malaria, as prompt recognition and intervention are vital in preventing serious neurological consequences. Option B) Anemia is a common complication of malaria, especially in pediatric patients, but it is not considered an uncommon complication. Anemia occurs due to the destruction of red blood cells by the malaria parasite. Option C) Hepatitis is not a typical complication of severe falciparum malaria in pediatric patients. While liver dysfunction can occur in malaria, it is usually due to the direct effects of the parasite on the liver rather than hepatitis. Option D) Jaundice is also not an uncommon complication of severe falciparum malaria in pediatric patients. Jaundice typically results from the breakdown of red blood cells and liver dysfunction, but it is not a distinctive feature of severe malaria. Educationally, understanding the potential complications of severe falciparum malaria in pediatric patients is essential for nurses working in regions where malaria is endemic. Recognizing these complications early can help in providing appropriate care and improving patient outcomes. It is crucial to differentiate between common and uncommon complications to ensure timely and effective management.

Question 4 of 5

Accepted maintenance treatment for chronic asthma includes the following:

Correct Answer: A

Rationale: In the management of chronic asthma in pediatric patients, the accepted maintenance treatment typically includes high-dose inhaled steroids and long-acting bronchodilators, which is option A. This combination therapy targets both the underlying inflammation (steroids) and bronchoconstriction (bronchodilators) seen in asthma. Option B, Montelukast, is a leukotriene receptor antagonist that can be used as an adjunctive therapy in asthma, but it is not typically considered first-line maintenance treatment. Option C, combining Montelukast and inhaled steroids, may be an option in some cases, but high-dose inhaled steroids are usually preferred over Montelukast as monotherapy for chronic asthma. Option D, using long-acting beta-agonists alone, is not recommended as monotherapy for chronic asthma in children due to the risk of exacerbating symptoms and the lack of anti-inflammatory effects. Educationally, it is important to understand the rationale behind each treatment option to provide optimal care for pediatric patients with asthma. By knowing which medications target inflammation, bronchoconstriction, or both, healthcare providers can tailor treatment plans to individual patient needs, ensuring better control of asthma symptoms and improved quality of life.

Question 5 of 5

Examples of encapsulated organisms are all except:

Correct Answer: A

Rationale: In the context of pediatric cardiovascular disorders nursing and pharmacology, understanding encapsulated organisms is crucial for effective patient care. Encapsulated organisms have a polysaccharide capsule that helps them evade the host's immune system. In this question, the correct answer is A) Pseudomonas. Pseudomonas is not an encapsulated organism, unlike the other options. B) Proteus, C) Pneumococci, and D) Salmonella are encapsulated organisms. Proteus species, Streptococcus pneumoniae (pneumococci), and Salmonella species have capsules that play a role in their pathogenicity. Identifying these organisms informs appropriate treatment strategies, such as targeted antibiotic therapy. Educationally, this question reinforces the importance of recognizing specific microbial characteristics to guide treatment decisions. Nurses need to be able to differentiate between encapsulated and non-encapsulated organisms to provide optimal care for pediatric patients with cardiovascular disorders. Understanding microbiology concepts like capsule formation can enhance nursing practice and improve patient outcomes.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions